LEXX — Lexaria Bioscience Corp.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1348362 ·
Last close
$4.18
Market Cap
$8.81M
52W High
$21.60
52W Low
$2.43
ADV30
45,369
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| May 2026 | 0 | 0 | -1,993,804 | -1,991,202 | 4,781,331 | 3,475,003 | 437,091 |
| Feb 2026 | 20,000 | 20,000 | -1,451,903 | -1,449,979 | 6,487,303 | 5,128,141 | 276,997 |
| Nov 2025 | 0 | 0 | -1,573,631 | -1,595,007 | 6,050,807 | 4,281,233 | 1,527,353 |
| Aug 2025 | 174,000 | 174,000 | -2,688,597 | -2,695,838 | 4,175,121 | 1,802,123 | 1,572,366 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,425,488
Investing CF
$-243,975
Financing CF
$6,518,105
CapEx
$-101,872
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.30
As of
2026-10-18
Balance + Analyst (yfinance extras)
Retained Earnings
$-68,496,801
Inventory
—
Receivables
$48,998
ST Investments
$142,103
EBIT TTM
$-7,707,935
Pretax Income TTM
$-7,736,041
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$194,000
EBITDA
$-7,417,538
Free Cash Flow
$-4,688,228
Enterprise Value
$2,636,051
Total Cash
$3,617,106
Total Debt
$86,714
Shares Out
2,106,487
Trailing EPS
$-5.10
Book Value
$2.87
ROE
-162.8%
ROA
-81.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Aug 2025 | 705,923 | -11,880,737 | -11,901,841 | 4,175,121 | 1,572,366 | 2,989,697 | -10,450,387 |
| Aug 2024 | 464,278 | -5,753,130 | -5,795,345 | 8,867,789 | 1,208,738 | 8,036,400 | -4,959,003 |
| Aug 2023 | 226,208 | -6,534,022 | -6,664,899 | 3,083,986 | 403,908 | 3,044,118 | -5,881,237 |
| Aug 2022 | 255,397 | -6,619,039 | -7,269,324 | 7,833,927 | 201,437 | 7,948,904 | -4,879,339 |
TTM Snapshot
Revenues TTM
$194,000
NetIncome TTM
$-7,732,026
OpCashFlow TTM
—
Assets (Latest)
$4,781,331
Forward EPS
$-0.39
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BFRI | Biofrontera Inc. | $8.81M | $0.59 | — |
| PHIO | Phio Pharmaceuticals Corp. | $8.57M | $0.72 | — |
| DARE | Dare Bioscience, Inc. | $8.44M | $0.43 | — |
| CALC | CalciMedica, Inc. | $8.41M | $1.22 | — |
| CLRB | Cellectar Biosciences, Inc. | $9.24M | $0.92 | — |
News headlines (Yahoo Finance, 1h cache)
LEXX: New Pharmaceutical Agreement
2026-11-09 08:00 · Yahoo
Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
2026-11-04 14:00 · Yahoo
Lexaria Celebrates its 70th Patent Award
2026-10-28 13:10 · Yahoo
Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
2026-10-21 13:25 · Yahoo
Lexaria Announces Results from Animal Study GLP-1-A26-1
2026-10-15 13:10 · Yahoo
GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
2026-10-06 13:10 · Yahoo
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
2026-09-08 12:00 · Yahoo
LEXX: Introducing DehydraTECH 3.0
2026-09-08 10:15 · Yahoo
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-04 13:20 · Yahoo
Lexaria Receives USD$2.6 Million Tax Rebate Payment
2026-09-01 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.